CN102875449B - 盐酸替罗非班异构体分离方法及d构型盐酸替罗非班定量方法 - Google Patents
盐酸替罗非班异构体分离方法及d构型盐酸替罗非班定量方法 Download PDFInfo
- Publication number
- CN102875449B CN102875449B CN201210388478.7A CN201210388478A CN102875449B CN 102875449 B CN102875449 B CN 102875449B CN 201210388478 A CN201210388478 A CN 201210388478A CN 102875449 B CN102875449 B CN 102875449B
- Authority
- CN
- China
- Prior art keywords
- configuration
- tirofiban hydrochloride
- solution
- trifluoroacetic acid
- acid aqueous
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 0 *[C@@](Cc1ccc(*C2CCNCC2)cc1)C(O)=O Chemical compound *[C@@](Cc1ccc(*C2CCNCC2)cc1)C(O)=O 0.000 description 1
Landscapes
- Treatment Of Liquids With Adsorbents In General (AREA)
Abstract
Description
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210388478.7A CN102875449B (zh) | 2012-10-15 | 2012-10-15 | 盐酸替罗非班异构体分离方法及d构型盐酸替罗非班定量方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210388478.7A CN102875449B (zh) | 2012-10-15 | 2012-10-15 | 盐酸替罗非班异构体分离方法及d构型盐酸替罗非班定量方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102875449A CN102875449A (zh) | 2013-01-16 |
CN102875449B true CN102875449B (zh) | 2014-08-06 |
Family
ID=47477004
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210388478.7A Active CN102875449B (zh) | 2012-10-15 | 2012-10-15 | 盐酸替罗非班异构体分离方法及d构型盐酸替罗非班定量方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102875449B (zh) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106596788B (zh) * | 2016-12-26 | 2019-05-03 | 上海微谱化工技术服务有限公司 | 一种心脑血管药物替罗非班s构型的分离检测方法 |
CN109696500B (zh) * | 2019-01-29 | 2021-07-09 | 中国药科大学 | 采用高效液相色谱法测定目标杂质校正因子的方法及应用 |
CN112578030B (zh) * | 2019-09-29 | 2022-10-04 | 扬子江药业集团四川海蓉药业有限公司 | 一种盐酸替罗非班注射液中对映异构体的检测方法 |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1076442A (zh) * | 1992-02-28 | 1993-09-22 | 麦克公司 | 制备纤维蛋白原受体拮抗剂的方法 |
WO2006076401A2 (en) * | 2005-01-12 | 2006-07-20 | Biovec, Llc | Composition for preserving platelets and method of using the same |
CN101756915A (zh) * | 2010-02-25 | 2010-06-30 | 山东新时代药业有限公司 | 盐酸替罗非班冻干粉针注射剂及制备方法 |
CN102125519A (zh) * | 2011-02-28 | 2011-07-20 | 正大青春宝药业有限公司 | 稳定的盐酸替罗非班注射液及其制备方法 |
CN102267937A (zh) * | 2011-06-03 | 2011-12-07 | 天津南开允公医药科技有限公司 | 一种盐酸替罗非班的制备方法 |
CN102423303A (zh) * | 2011-11-21 | 2012-04-25 | 山东新时代药业有限公司 | 一种盐酸替罗非班注射用冻干粉针剂 |
CN102600072A (zh) * | 2012-03-31 | 2012-07-25 | 武汉同源药业有限公司 | 盐酸替罗非班注射液及其制备方法 |
-
2012
- 2012-10-15 CN CN201210388478.7A patent/CN102875449B/zh active Active
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1076442A (zh) * | 1992-02-28 | 1993-09-22 | 麦克公司 | 制备纤维蛋白原受体拮抗剂的方法 |
WO2006076401A2 (en) * | 2005-01-12 | 2006-07-20 | Biovec, Llc | Composition for preserving platelets and method of using the same |
CN101756915A (zh) * | 2010-02-25 | 2010-06-30 | 山东新时代药业有限公司 | 盐酸替罗非班冻干粉针注射剂及制备方法 |
CN102125519A (zh) * | 2011-02-28 | 2011-07-20 | 正大青春宝药业有限公司 | 稳定的盐酸替罗非班注射液及其制备方法 |
CN102267937A (zh) * | 2011-06-03 | 2011-12-07 | 天津南开允公医药科技有限公司 | 一种盐酸替罗非班的制备方法 |
CN102423303A (zh) * | 2011-11-21 | 2012-04-25 | 山东新时代药业有限公司 | 一种盐酸替罗非班注射用冻干粉针剂 |
CN102600072A (zh) * | 2012-03-31 | 2012-07-25 | 武汉同源药业有限公司 | 盐酸替罗非班注射液及其制备方法 |
Non-Patent Citations (8)
Title |
---|
Determination of MK-383, a non-peptide fibrinogen receptor antagonist, in human plasma and urine by radioimmunoassay;E.L.HAND,等;《Journal of Pharmaceutical and Biomedical Analysis》;19940831;第12卷(第8期);第1047-1053页 * |
DEVELOPMENT AND VALIDATION OF NEW RP-HPLC METHOD FOR THE DETERMINATION OF TIROFIBAN IN PHARMACEUTICAL FORMULATION;K. Sridevi Ranjitha,等;《IJPCBS》;20111231;第1卷(第1期);第43-47页 * |
E.L.HAND,等.Determination of MK-383, a non-peptide fibrinogen receptor antagonist, in human plasma and urine by radioimmunoassay.《Journal of Pharmaceutical and Biomedical Analysis》.1994,第12卷(第8期),第1047–1053页. |
Joan D.Ellis,等.Use of LC-MS/MS to cross-validate a radioimmunoassay for the fibrinogen receptor antagonist, Aggrastat (tirofiban hydrochloride) in human plasma.《Journal of Pharmaceutical and Biomedical Analysis》.1997,第15卷(第5期),第561–569页. |
K. Sridevi Ranjitha,等.DEVELOPMENT AND VALIDATION OF NEW RP-HPLC METHOD FOR THE DETERMINATION OF TIROFIBAN IN PHARMACEUTICAL FORMULATION.《IJPCBS》.2011,第1卷(第1期),第43-47页. |
Use of LC-MS/MS to cross-validate a radioimmunoassay for the fibrinogen receptor antagonist, Aggrastat (tirofiban hydrochloride) in human plasma;Joan D.Ellis,等;《Journal of Pharmaceutical and Biomedical Analysis》;19970228;第15卷(第5期);第561-569页 * |
紫外分光光度法测定盐酸替罗非班氯化钠注射液中主药的含量;黄荣富,等;《中国药房》;20100203;第21卷(第05期);第451-452页 * |
黄荣富,等.紫外分光光度法测定盐酸替罗非班氯化钠注射液中主药的含量.《中国药房》.2010,第21卷(第05期),第451-452页. |
Also Published As
Publication number | Publication date |
---|---|
CN102875449A (zh) | 2013-01-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105424822B (zh) | 检测替格瑞洛中(1r,2s)‑2‑(3,4‑二氟苯基)环丙胺的方法 | |
CN102875449B (zh) | 盐酸替罗非班异构体分离方法及d构型盐酸替罗非班定量方法 | |
CN111948306B (zh) | 一种测定苯磺酸氨氯地平中基因毒性杂质的方法 | |
CN113009003A (zh) | 一种盐酸伊托必利制剂中有关物质的检测方法 | |
CN113702514A (zh) | 一种阿托伐他汀钙有关杂质ⅰ的测定方法 | |
Thangabalan et al. | Analytical method development and validation of natamycin in eye drop by RP-HPLC | |
CN105181859A (zh) | 对乙酰氨基酚注射液中盐酸半胱氨酸及降解产物胱氨酸的测定方法 | |
Nageswara Rao et al. | Simultaneous separation and determination of process‐related substances and degradation products of venlafaxine by reversed‐phase HPLC | |
CN105004803A (zh) | 一种分离测定托伐普坦中多个杂质的液相色谱方法 | |
CN110243971A (zh) | 利用hplc-elsd检测1,4,7,10-四氮杂环十二烷及其衍生物含量的方法 | |
CN115656360A (zh) | 富马酸伏诺拉生中间体的质量控制方法 | |
CN110530992B (zh) | 一种盐酸左布比卡因注射液光学异构体的检验方法 | |
CN113848271A (zh) | 一种检测盐酸左西替利嗪口服溶液中有关物质的方法 | |
CN113607836A (zh) | 一种茚虫威关键中间体含量的分析方法 | |
GA et al. | VALIDATED RP-HPLC AND UV-SPECTROSCOPY METHODS FOR THE ESTIMATION OF DAPAGLIFLOZIN IN BULK AND IN TABLETS. | |
Chadalawada et al. | RP-HPLC analytical method development and validation of metformin hydrochloride tablets assay | |
CN109001342B (zh) | 一种检测n-2,3-二甲氧苄基胡椒乙胺及其盐含量的高效液相方法 | |
CN103336067B (zh) | 一种检测替诺福韦二乙酯含量的高效液相检测方法 | |
Nekkala et al. | Stability indicating RP-HPLC method for quantification of impurities in fosamprenavir calcium drug substance | |
CN105675754A (zh) | 高效液相色谱法测定利格列汀对映异构体含量的方法 | |
CN113671085B (zh) | 一种缬沙坦中的2-叠氮基-3-甲基丁酸的检测方法 | |
CN109633011A (zh) | 一种新的甘氨酸含量的检测方法 | |
Onal et al. | Development and validation of a stability-indicating ultra-fast liquid chromatographic analysis for the simultaneous determination of fenticonazole and its related substances in pharmaceutical formulations | |
CN113219105B (zh) | 一种艾司奥美拉唑镁及其中间体中2-硝基-4-甲氧基苯胺的检测方法 | |
Ulu | High performance liquid chromatographic method for the determination of norfloxacin in pharmaceutical preparation after pre-column derivatization |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C56 | Change in the name or address of the patentee | ||
CP01 | Change in the name or title of a patent holder |
Address after: Tianjin City, Nankai District road 300384 yuan Huayuan new technology industrial park, 5 block D No. 9 Patentee after: Nankai Yungong Pharmaceutical Science-Technology Co., Ltd., Tianjin Patentee after: Tongliao Huabang Pharmaceutical Co Ltd Address before: Tianjin City, Nankai District road 300384 yuan Huayuan new technology industrial park, 5 block D No. 9 Patentee before: Nankai Yungong Pharmaceutical Science-Technology Co., Ltd., Tianjin Patentee before: Naikai Share Pharmaceutical Co., Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20190529 Address after: 028100 Tiedong, Ganqika Town, Kezuo Houqi, Tongliao City, Inner Mongolia Autonomous Region Patentee after: Tongliao Huabang Pharmaceutical Co Ltd Address before: 300384 9/F, Block D, No. 5 Lanyuan Road, Huayuan New Technology Industrial Park, Nankai District, Tianjin Co-patentee before: Tongliao Huabang Pharmaceutical Co Ltd Patentee before: Nankai Yungong Pharmaceutical Science-Technology Co., Ltd., Tianjin |